Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Lei, Liang ^a,b   Sonabend, Adam M ^b   Guarnieri, Paolo ^b   Soderquist, Craig ^a   Ludwig, Thomas ^a,b   Rosenfeld, Steven ^b   Bruce, Jeffrey N ^b   Canoll, Peter ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE CLASSIFICATION; EARLY CANCER; GENE EXPRESSION; GLIOBLASTOMA; GROWTH RATE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; MOUSE; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; RETROVIRUS; STEM CELL; TUMOR GROWTH; TUMOR LOCALIZATION; BIOLOGICAL MODEL; CYTOLOGY; GLIA; PATHOLOGY;

GLIOBLASTOMA; HUMANS; MODELS, BIOLOGICAL; NEUROGLIA; STEM CELLS;

EID: 79956361405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020041     Document Type: Article

References (102)

1. Stiles CD, Rowitch DH, (2008) Glioma stem cells: a midterm exam. Neuron 58: 832-846.
2. Huse JT, Holland EC, (2010) Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer 10: 319-331.
3. Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, et al. (2004) Gene Expression Profiling of Gliomas Strongly Predicts Survival. Cancer Research 64: 6503-6510.
4. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, et al. (2005) Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma. Cancer Research 65: 1678-1686.
5. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, et al. (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America 102: 5814-5819.
6. Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, et al. (2005) Gene Expression Profiling and Genetic Markers in Glioblastoma Survival. Cancer Research 65: 4051-4058.
7. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173.
8. TCGA (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
9. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
10. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
11. Uhrbom L, Hesselager G, Nister M, Westermark B, (1998) Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 58: 5275-5279.
12. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, et al. (2001) PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15: 1913-1925.
13. Xiao A, Wu H, Pandolfi PP, Louis DN, Van Dyke T, (2002) Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1: 157-168.
14. Hesselager G, Uhrbom L, Westermark B, Nister M, (2003) Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res 63: 4305-4309.
15. Xiao A, Yin C, Yang C, Di Cristofano A, Pandolfi PP, et al. (2005) Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. Cancer Res 65: 5172-5180.
16. Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, et al. (2005) Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8: 119-130.
17. Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, et al. (2006) Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci 26: 6781-6790.
18. Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, et al. (2006) PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51: 187-199.
19. Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, et al. (2008) p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455: 1129-1133.
20. Wang Y, Yang J, Zheng H, Tomasek GJ, Zhang P, et al. (2009) Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 15: 514-526.
21. Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L, (2009) Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene 28: 2266-2275.
22. Assanah MC, Bruce JN, Suzuki SO, Chen A, Goldman JE, et al. (2009) PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia 57: 1835-1847.
23. Hede S-M, Hansson I, Afink GB, Eriksson A, Nazarenko I, et al. (2009) GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background. Glia 57: 1143-1153.
24. Marumoto T, Tashiro A, Friedmann-Morvinski D, Scadeng M, Soda Y, et al. (2009) Development of a novel mouse glioma model using lentiviral vectors. Nat Med 15: 110-116.
25. Alcantara Llaguno S, Chen J, Kwon CH, Jackson EL, Li Y, et al. (2009) Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15: 45-56.
26. Jacques TS, Swales A, Brzozowski MJ, Henriquez NV, Linehan JM, et al. (2010) Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J 29: 222-235.
27. Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, et al. (2010) Non-Stem Cell Origin for Oligodendroglioma. Cancer Cell 18: 669-682.
28. Canoll P, Goldman J, (2008) The interface between glial progenitors and gliomas. Acta Neuropathologica 116: 465-477.
29. Dolores Hambardzumyan NMA, Helmy KarimY, Becher OrenJ, Holland EricC, (2009) Modeling Adult Gliomas Using RCAS/t-va Technology. Translational Oncology 2: 89-95.
30. Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, et al. (2000) Proliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord. J Neurosci 20: 2218-2228.
31. Gensert JM, Goldman JE, (2001) Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter. Journal of Neurobiology 48: 75-86.
32. Zhu X, Bergles DE, Nishiyama A, (2008) NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 135: 145-157.
33. Roy NS, Wang S, Harrison-Restelli C, Benraiss A, Fraser RAR, et al. (1999) Identification, Isolation, and Promoter-Defined Separation of Mitotic Oligodendrocyte Progenitor Cells from the Adult Human Subcortical White Matter. J Neurosci 19: 9986-9995.
34. Dawson MRL, Polito A, Levine JM, Reynolds R, (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Molecular and Cellular Neuroscience 24: 476-488.
35. Rhee W, Ray S, Yokoo H, Hoane ME, Lee CC, et al. (2009) Quantitative analysis of mitotic Olig2 cells in adult human brain and gliomas: Implications for glioma histogenesis and biology. Glia 57: 510-523.
36. Chong SYC, Chan JR, (2010) Tapping into the glial reservoir: cells committed to remaining uncommitted. The Journal of Cell Biology 188: 305-312.
37. Geha S, Pallud J, Junier M-P, Devaux B, Leonard N, et al. (2010) NG2+/Olig2+ Cells are the Major Cycle-Related Cell Population of the Adult Human Normal Brain. Brain Pathology 20: 399-411.
38. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, et al. (2010) Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466: 632-636.
39. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, et al. (2010) Subtypes of medulloblastoma have distinct developmental origins. Nature 468: 1095-1099.
40. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, et al. (2009) Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations. PLoS One 4: e7752.
41. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, et al. (1996) GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17: 229-243.
42. Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, et al. (2004) Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 64: 4783-4789.
43. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264-278.
44. Sun L, Hui A-M, Su Q, Vortmeyer A, Kotliarov Y, et al. (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
45. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proceedings of the National Academy of Sciences 104: 20007-20012.
46. Riley T, Sontag E, Chen P, Levine A, (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9: 402-412.
47. Vousden KH, Prives C, (2009) Blinded by the Light: The Growing Complexity of p53. Cell 137: 413-431.
48. Zhu Y, Prives C, (2009) p53 and Metabolism: The GAMT Connection. Molecular Cell 36: 351-352.
49. Kesari S, Stiles CD, (2006) The bad seed: PDGF receptors link adult neural progenitors to glioma stem cells. Neuron 51: 151-153.
50. Pei Y, Wechsler-Reya RJ, (2010) A Malignant Oligarchy: Progenitors Govern the Behavior of Oligodendrogliomas. Cancer Cell 18: 546-547.
51. Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, et al. (2006) Loss of p53 Induces Changes in the Behavior of Subventricular Zone Cells: Implication for the Genesis of Glial Tumors. J Neurosci 26: 1107-1116.
52. Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, et al. (2007) Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant Glioma. Neuron 53: 503-517.
53. Bohman L-E, (2010) Magnetic Resonance Imaging Characteristics of Glioblastoma Multiforme: Implications for Understanding Glioma Ontogeny. Neurosurgery 67: 1319-1328.
54. Lim DA, Cha S, Mayo MC, Chen M-H, Keles E, et al. (2007) Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-Oncology 9: 424-429.
55. Kappadakunnel M, Eskin A, Dong J, Nelson S, Mischel P, et al. (2010) Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone. Journal of Neuro-Oncology 96: 359-367.
56. Lewis PF, Emerman M, (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68: 510-516.
57. Levison SW, Goldman JE, (1993) Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 10: 201-212.
58. Levison SW, Young GM, Goldman JE, (1999) Cycling cells in the adult rat neocortex preferentially generate oligodendroglia. Journal of Neuroscience Research 57: 435-446.
59. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, et al. (2002) Functional neurogenesis in the adult hippocampus. Nature 415: 1030-1034.
60. Hart IK, Richardson WD, Heldin CH, Westermark B, Raff MC, (1989) PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage. Development 105: 595-603.
61. Pringle NP, Mudhar HS, Collarini EJ, Richardson WD, (1992) PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115: 535-551.
62. Barres BA, Schmid R, Sendnter M, Raff MC, (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118: 283-295.
63. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, et al. (1998) Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20: 869-882.
64. McKinnon RD, Waldron S, Kiel ME, (2005) PDGF {alpha}-Receptor Signal Strength Controls an RTK Rheostat That Integrates Phosphoinositol 3′-Kinase and Phospholipase C{gamma} Pathways during Oligodendrocyte Maturation. J Neurosci 25: 3499-3508.
65. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P, (1988) Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor ceil. Nature 333: 560-562.
66. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD, (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562-565.
67. Armstrong RC, Harvath L, Dubois-Dalcq ME, (1990) Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. Journal of Neuroscience Research 27: 400-407.
68. Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, et al. (1999) Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126: 457-467.
69. Klinghoffer RA, Hamilton TG, Hoch R, Soriano P, (2002) An Allelic Series at the PDGF±R Locus Indicates Unequal Contributions of Distinct Signaling Pathways During Development. Developmental cell 2: 103-113.
70. Cooper LAD, Gutman DA, Long Q, Johnson BA, Cholleti SR, et al. (2009) The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas. PLoS One 5: e12548.
71. Chow Lionel ML, Endersby R, Zhu X, Rankin S, Qu C, et al. (2011) Cooperativity within and among Pten, p53, and Rb Pathways Induces High-Grade Astrocytoma in Adult Brain. Cancer cell 19: 305-316.
72. Prives C, (1998) Signaling to p53: Breaking the MDM2-p53 Circuit. Cell 95: 5-8.
73. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522.
74. Wright KD, Gilbertson RJ, (2010) To Infinium, and Beyond! Cancer Cell 17: 419-420.
75. Matsuda T, Cepko CL, (2007) Controlled expression of transgenes introduced by in vivo electroporation. Proceedings of the National Academy of Sciences 104: 1027-1032.
76. Tashiro A, Zhao C, Gage FH, (2006) Retrovirus-mediated single-cell gene knockout technique in adult newborn neurons in vivo. Nat Protoc 1: 3049-3055.
77. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, et al. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1: 4.
78. Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A, et al. (2001) Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294: 2186-2189.
79. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730.
80. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
81. Jo McEntyre JO, (2002) The NCBI Handbook; In: Jo McEntyre JO, editors.
82. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, et al. (2011) Database resources of the National Center for Biotechnology Information. Nucleic Acids Research 39: D38-D51.
83. Katagiri F, Glazebrook J, (2001) Pattern Discovery in Expression Profiling Data John Wiley & Sons, Inc.
84. D'Haeseleer P, (2005) How does gene expression clustering work? Nat Biotech 23: 1499-1501.
85. Dabney AR, (2006) Classification of microarrays to nearest centroids. Bioinformatics 21: 4148-4154.
86. Jean(ZHIJIN) Wu RI, MacDonald James, Gentry Jeff, gcrma: Background Adjustment Using Sequence Information. R package version 2.16.0.
87. Smyth G, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol pp. 3.
88. Smyth GK, (2005) Limma: linear models for microarray data. In: Gentleman VC R, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor New York Springer pp. 397-420.
89. Gautier L, Cope L, Bolstad BM, Irizarry RA, (2004) affy analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315.
90. Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5: R80.
91. Gentleman RCV, Huber W, Irizarry R, Dudoit S, S, (2005) Bioinformatics and Computational Biology Solutions Using R and Bioconductor.
92. Wilson CL, Miller CJ, (2005) Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 21: 3683-3685.
93. Team R (2009) R Development Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
94. Kooperberg C, Aragaki A, Strand AD, Olson JM, (2005) Significance testing for small microarray experiments. Statistics in Medicine 24: 2281-2298.
95. Jeffery I, Higgins D, Culhane A, (2006) Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics 7: 359.
96. Murie C, Woody O, Lee A, Nadon R, (2009) Comparison of small n statistical tests of differential expression applied to microarrays. BMC Bioinformatics 10: 45.
97. Jeanmougin M, de Reynies A, Marisa L, Paccard C, Nuel G, et al. (2010) Should We Abandon the t-Test in the Analysis of Gene Expression Microarray Data: A Comparison of Variance Modeling Strategies. PLoS One 5: e12336.
98. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F, (2004) A Model-Based Background Adjustment for Oligonucleotide Expression Arrays. Journal of the American Statistical Association 99: 909-917.
99. Irizarry RA, Wu Z, Jaffee HA, (2006) Comparison of Affymetrix GeneChip expression measures. Bioinformatics 22: 789-794.
100. Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, et al. (2003) PGC-1[alpha]-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
101. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102: 15545-15550.
102. Lim WKLE, Califano A, (2009) Master regulators used as breast cancer metastasis classifier. Pac Symp Biocomput pp. 504-515.